Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FAVYP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,354
Award facts
- Contract value 100% obligated
- $12,353.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $12,353.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 8, 2025. The contract calls for the delivery of Enbrel 50 mg/mL SureClick auto-injectors to support military healthcare operations, with an ultimate completion date of August 11, 2025. This delivery order was issued without a set-aside designation, and performance will occur in Conshohocken, Pennsylvania. DMS Pharmaceutical Group, based in Park Ridge, Illinois, leveraged its established relationship with DLA to secure this order.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and effective through November 2026. The IDC serves as the primary vehicle enabling DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables, to support Department of Defense healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently maintained a robust portfolio of delivery orders covering diverse medical products ranging from specialty medications to injectable treatments that support military medical operations globally.
Quick answers
Who was awarded contract SPE2DB25FAVYP?
SPE2DB25FAVYP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FAVYP worth?
The government has obligated $12,354 on SPE2DB25FAVYP.
Is contract SPE2DB25FAVYP an order under another contract?
Yes. SPE2DB25FAVYP is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVYP competed?
The extent of competition for SPE2DB25FAVYP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award